UNA REVISIÓN LITERARIA DEL TRATAMIENTO CON SUPRESOR HORMONAL EN NIÑOS Y ADOLESCENTES INCONGRUENTES DE GÉNERO
Barra lateral del artículo
Contenido principal del artículo
Resumen
Objetivo: debatir los impactos que la evidencia actual puede tener sobre el uso de bloqueantes hormonales en menores diagnosticados de Incongruencia de Género. Fuente de datos: Se realizó una revisión sistemática de la literatura sobre “Disforia de género” entre 1961 y 2013, compuesta por 11 revistas extraídas del repositorio digital PubMed, dos fuentes literarias y una tesis. El método de análisis adoptado fue hipotético-deductivo y la revisión sistemática se basó en el metanálisis. Síntesis de datos: se encontró de una muestra de 511 niños y adolescentes, mayores de 52 años, solo 98 (19%) persistieron con síntomas disfóricos en la edad adulta sin la administración de inhibidores hormonales, mientras que los que se basaron en terapia hormonal tuvieron un 100% tasa de persistencia. Discusión: la administración de inhibidores hormonales por GNHRa, teóricamente, puede inducir la persistencia de la incongruencia de género y sus efectos a largo plazo son desconocidos para la ciencia, ya que no existe consenso científico sobre el producto en niños y adolescentes.
Detalles del artículo
Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
Copyright (c). Boletim de Coyuntura (BOCA)
Este obra está bajo una licencia de Creative Commons Reconocimiento 4.0 Internacional.
Citas
APA - American Psychiatric Association. Manual diagnóstico e estatístico de transtornos mentais: DSM-5. Porto Alegre: Artmed, 2014.
BAKWIN, H. “Deviant gender-role behavior in children: Relation to homosexuality”. Pediatrics, vol. 41, n. 3, 1968.
BIGGS, M. “Puberty blockers and suicidality in adolescents suffering from gender dysphoria”. Archives of Sexual Behavior, vol. 49, 2020.
COHEN‐KETTENIS, P. T.; DELEMARRE‐VAN, H.A.; GOOREN, L.J.G. “The Treatment of Adolescent Transsexuals: Changing Insights”. The Journal of Sexual Medicine, vol. 5, n. 8, 2008.
COHEN-KETTENIS, P. T.; STEENSMA, T. D.; DE VRIES, A. L. “Treatment of adolescents with gender dysphoria in the Netherlands”. Child and Adolescent Psychiatric Clinics, vol. 20, n. 4, 2011.
D’ANGELO, R. et al. “One Size Does Not Fit All: In Support of Psychotherapy for Gender Dysphoria”. Archives of Sexual Behavior, vol. 50, n. 1, 2021.
DAVENPORT, C. W. “A follow-up study of 10 feminine boys”. Archives of Sexual Behavior, vol. 16, n. 6, 1986.
DE VRIES, A. L. “Challenges in Timing Puberty Suppression for Gender-Nonconforming Adolescents”. Pediatrics, vol. 146, n. 4, 2020.
DE VRIES, A. L.; STEENSMA, T. D.; DORELEIJERS, T. A.; COHEN‐KETTENIS, P. T. “Puberty suppression in adolescents with gender identity disorder: A prospective follow‐up study”. The Journal of Sexual Medicine, vol. 8, n. 8, 2011.
DELEMARRE-VAN, H. A.; COHEN-KETTENIS, P. T. “Clinical management of gender identity disorder in adolescents: a protocol on psychological and paediatric endocrinology aspects”. European Journal of Endocrinology, vol. 155, 2006.
DRUMMOND, K. D. et al. “A follow-up study of girls with gender identity disorder”. Developmental psychology, vol. 44, n. 1, 2008.
GIORDANO, S. “Gender atypical organisation in children and adolescents: ethico-legal issues and a proposal for new guidelines”. The International Journal of Children's Rights, vol. 15, n. 3, 2007.
GIOVANARDI, G. “Buying time or arresting development? The dilemma of administering hormone blockers in trans children and adolescents”. Porto Biomedical Journal, vol. 2, n. 5, 2017.
GREEN, R. The "sissy boy syndrome" and the development of homosexuality. New Haven: Yale University Press; 1987.
GREEN, R.; MONEY, J. “Effeminacy in prepubertal boys: Summary of eleven cases and recommendations for case management”. Pediatrics, vol. 27, n. 2, 1961.
HEMBREE, W. C. “Guidelines for pubertal suspension and gender reassignment for transgender adolescents”. Child and Adolescent Psychiatric Clinics, vol. 20, n. 4, 2011.
HRUZ, P. W.; MAYER, L. S.; MCHUGH, P. R. “Growing pains: problems with puberty suppression in treating gender dysphoria. The New Atlantis, June, 2017.
KLINK, D. et al. “Bone mass in young adulthood following gonadotropin-releasing hormone analog treatment and cross-sex hormone treatment in adolescents with gender dysphoria”. The Journal of Clinical Endocrinology & Metabolism, vol. 100, n. 2, 2015.
KORTE, A. et al. “Gender identity disorders in childhood and adolescence: currently debated concepts and treatment strategies”. Deutsches Ärzteblatt International, vol. 105, n. 48, 2008.
KOSKY, R.J. “Gender‐disordered children: does inpatient treatment help?” Medical Journal of Australia, vol. 146, n. 11, 1987.
LEBOVITZ, P.S. “Feminine behaviour in boys: Aspects of its outcome”. American Journal of Psychiatry, vol. 28, n. 10, 1972.
LIBERATI A. et al. “The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration”. PLoS Medicine, vol. 6, n. 7, 2009.
MILROD, C. “How young is too young: ethical concerns in genital surgery of the transgender MTF adolescent”. The Journal of Sexual Medicine, vol. 11, n. 2, 2014.
MONEY, J.; RUSSO, A.J. “Homosexual outcome of discordant gender identity/role in childhood: Longitudinal follow-up”. Journal of Pediatric Psychology, vol. 41, n. 1, 1979.
PILGRIM, D.; ENTWISTL, K. “GnRHa (‘Puberty Blockers’) and Cross Sex Hormones for Children and Adolescents: Informed Consent, Personhood and Freedom of Expression”. The New Bioethics, vol. 26, n. 3, 2020.
RICHARDS, C.; MAXWELL J.; McCUNE, N. “Use of puberty blockers for gender dysphoria: a momentous step in the dark”. Arch Dis Child, vol. 104, 2019.
SADJADI, S. “The endocrinologist’s office — puberty suppression: Saving children from a natural disaster?” Journal of Medical Humanities, vol. 34, n. 2, 2013.
SIERRA, M. C. “Menores transgénero en el Reino Unido: Polémica por la investigación sobre bloqueadores puberales”. Revista Clínica Contemporánea, vol. 10, n. 25, 2019.
SINGH, D. A follow-up study of boys with gender identity disorder (Master´s Thesis). Toronto: University of Toronto; 2012.
SEGM - Society for Evidence-Based Gender Medicine. “Sweden's Karolinska Ends the Use of Puberty Blockers for <16: New policy statement from the Karolinska Hospital”. SEGM [05/05/2021]. 2021. Retrieved from: <https://segm.org>. Access in: 07/05/2021.
STEENSMA, T. D. et al. “Factors associated with desistence and persistence of childhood gender dysphoria: a quantitative follow-up study”. Journal of the American Academy of Child & Adolescent Psychiatry, vol. 52, n. 6, 2013.
VAZ, J. L. D. “Questões epistemológicas fundamentais na investigação em gestão: o método hipotético dedutivo”. Estudos de Gestão, vol. 4, n. 2, 1998.
VLOT, M. C. et al. “Effect of pubertal suppression and cross-sex hormone therapy on bone turnover markers and bone mineral apparent density (BMAD) in transgender adolescents”. Bone, vol. 95, 2017.
WALLIEN, M. S.; COHEN-KETTENIS, P. T. “Psychosexual outcome of gender-dysphoric children”. Journal of the American Academy of Child & Adolescent Psychiatry, vol. 47, n. 12, 2008.
WHO - World Health Organization. “International classification of diseases for mortality and morbidity statistics: (ICD: 11th Revision)”. WHO [05/2021]. Retrieved from: <https://icd.who.int>. Access in: 08/31/2021.
ZUGER, B. “Early effeminate behavior in boys: Outcome and significance for homosexuality”. Journal of Nervous and Mental Disease, vol. 172, n. 2, 1984.
ZUGER, B. “Effeminate behaviour present in boys from childhood: Ten additional years of follow-up”. Comprehensive Psychiatry, vol. 19, n. 4, 1978.